Publications by authors named "Satoshi Wasamoto"

Claim this Profile
C
Cobblestone Airway from Infection.
Satoru Yanagisawa, Yuki Todoroki, Hiroki Takechi, Satoshi Wasamoto

Am J Respir Crit Care Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stool eosinophils and immune-related adverse event-enterocolitis.
Satoru Yanagisawa, Takaya Yui, Yuki Kozu, Hiroki Takechi, Satoshi Wasamoto

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleomorphic Lung Carcinoma Response to Treatment With BRAF and MEK Inhibitors: A Case Report.
Hideki Endoh, Satoshi Wasamoto

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer.
Satoshi Wasamoto, Hisao Imai, Takeshi Tsuda, Yoshiaki Nagai, Takayuki Kishikawa

Intern Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab-Induced Immune-Related Pneumonia on Rounded Atelectasis.
Satoru Yanagisawa, Takaya Yui, Hiroki Takechi, Satoshi Wasamoto

Clin Respir J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
Fuyumi Nishihara-Kato, Hisao Imai, Takeshi Tsuda, Satoshi Wasamoto, Yoshiaki Nagai

Oncology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Yoshiaki Nagai, Takayuki Kishikawa

Thorac Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer.
Ayako Shiono, Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Yoshiaki Nagai

Cancer Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
Satoshi Wasamoto, Hisao Imai, Takeshi Tsuda, Yoshiaki Nagai, Hiroyuki Minemura

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
Hisao Imai, Yoshiaki Nagai, Hiroyuki Minemura, Takeshi Tsuda, Yutaka Yamada, Satoshi Wasamoto

Invest New Drugs· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.
Ken Masubuchi, Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Hiroyuki Minemura

Thorac Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.
Taisuke Araki, Kazunari Tateishi, Masamichi Komatsu, Kei Sonehara, Satoshi Wasamoto

Thorac Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wheezing and Weightlifting.
Satoru Yanagisawa, Satoshi Wasamoto, Hiroki Takechi, Yuki Hata

Intern Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luminal Findings of a Bronchogenic Cyst.
Satoru Yanagisawa, Satoshi Wasamoto

Am J Respir Crit Care Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity.
Akimasa Sekine, Satoshi Wasamoto, Eri Hagiwara, Hideaki Yamakawa, Satoshi Ikeda

Respir Investig· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
Hisao Imai, Hiroyuki Minemura, Takayuki Kishikawa, Yutaka Yamada, Kensuke Suzuki, Satoshi Wasamoto

Thorac Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
Ou Yamaguchi, Hisao Imai, Hiroyuki Minemura, Kensuke Suzuki, Satoshi Wasamoto

Cancer Chemother Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
Hisao Imai, Satoshi Wasamoto, Ou Yamaguchi, Kensuke Suzuki, Tomohide Sugiyama

J Cancer Res Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary "Finger-in-glove" Sign on Fluorodeoxyglucose-positron Emission Tomography.
Satoru Yanagisawa, Satoshi Wasamoto, Hideki Endoh

Intern Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis